SRP-1003 IV Infusion, SRP-1003 SC Injection — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy
Phase 1/2 · Myotonic Dystrophy 1 |
SRPT Sarepta Therapeutics, Inc. | SRP-1003 IV Infusion, SRP-1003 SC Inject |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|